BACKGROUND: The impact of nonalcoholic fatty liver disease (NAFLD) comprising simple steatosis (NAFL) and steatohepatitis (NASH) on liver recovery after partial hepatectomy has not been evaluated. This pilot study investigated whether there is an effect of proven NAFLD on liver recovery. METHODS: Thirty-one patients elected for partial hepatectomy were characterized and included into a prospective study. Liver samples were staged according to the NAFLD activity score. Liver function was measured by using the LiMAx method on postoperative days (POD) 1, 3, 5, and 10. RESULTS: Nineteen patients were identified to suffer from NAFLD (NAFL, n = 11; NASH, n = 8). In NAFL, preoperative liver function (p = .48) and hepatic recovery on POD 1, 3, and 5 was comparable to controls (p > .05, respectively), while it was impaired on POD 10 (p = .022). NASH patients had preoperative enzymatic function comparable to controls (p = .10), but there was a trend to reduced levels on POD 1 (p = .082) and 5 (p = .062), which became significant on POD 10 (p = .003). CONCLUSION: This study suggests that NAFLD impairs functional recovery assessed by LiMAx after partial hepatectomy.
BACKGROUND: The impact of nonalcoholic fatty liver disease (NAFLD) comprising simple steatosis (NAFL) and steatohepatitis (NASH) on liver recovery after partial hepatectomy has not been evaluated. This pilot study investigated whether there is an effect of proven NAFLD on liver recovery. METHODS: Thirty-one patients elected for partial hepatectomy were characterized and included into a prospective study. Liver samples were staged according to the NAFLD activity score. Liver function was measured by using the LiMAx method on postoperative days (POD) 1, 3, 5, and 10. RESULTS: Nineteen patients were identified to suffer from NAFLD (NAFL, n = 11; NASH, n = 8). In NAFL, preoperative liver function (p = .48) and hepatic recovery on POD 1, 3, and 5 was comparable to controls (p > .05, respectively), while it was impaired on POD 10 (p = .022). NASH patients had preoperative enzymatic function comparable to controls (p = .10), but there was a trend to reduced levels on POD 1 (p = .082) and 5 (p = .062), which became significant on POD 10 (p = .003). CONCLUSION: This study suggests that NAFLD impairs functional recovery assessed by LiMAx after partial hepatectomy.
Authors: Zhao Shan; Gloria Alvarez-Sola; Iker Uriarte; María Arechederra; Maite G Fernández-Barrena; Carmen Berasain; Cynthia Ju; Matías A Avila Journal: Ann Transl Med Date: 2018-06
Authors: Johannes Roth; Oliver Sommerfeld; Andreas L Birkenfeld; Christoph Sponholz; Ulrich A Müller; Christian von Loeffelholz Journal: Dtsch Arztebl Int Date: 2021-09-17 Impact factor: 5.594
Authors: Florian Wolfgang Rudolf Vondran; Carsten Schumacher; Kai Johanning; Björn Hartleben; Wolfgang Knitsch; Olaf Wiesner; Elmar Jaeckel; Michael Peter Manns; Juergen Klempnauer; Hueseyin Bektas; Frank Lehner Journal: Case Rep Transplant Date: 2016-05-04
Authors: M Pilar Valdecantos; Laura Ruiz; Virginia Pardo; Luis Castro-Sanchez; Carmelo García-Monzón; Borja Lanzón; Javier Rupérez; Coral Barbas; Jaqueline Naylor; James L Trevaskis; Joseph Grimsby; Cristina M Rondinone; Ángela M Valverde Journal: Sci Rep Date: 2018-11-07 Impact factor: 4.379
Authors: M Stockmann; F W R Vondran; R Fahrner; H M Tautenhahn; J Mittler; H Bektas; M Malinowski; M Jara; I Klein; J F Lock Journal: BJS Open Date: 2018-06-14
Authors: Ivo J Schurink; Jubi E de Haan; Jorke Willemse; Matteo Mueller; Michael Doukas; Henk Roest; Femke H C de Goeij; Wojciech G Polak; Jan N M Ijzermans; Philipp Dutkowski; Luc J W van der Laan; Jeroen de Jonge Journal: Sci Rep Date: 2021-12-06 Impact factor: 4.379